Therapeutic Sequences in Patients with G1-G2 Neuroendocrine Tumors (NETs): An Observational, Multicentre, Prospective/Retrospective Study

#2194

Introduction: Many different therapies are suggested by guidelines to treat loco-regionally advanced or metastatic G1-G2 neuroendocrine tumors (NETs). However, a precise therapeutic algorithm has not yet been established.

Aim(s): This study aims at investigating the efficacy of different therapeutic sequences in a homogeneous population of G1-G2 NETs.

Materials and methods: An observational Italian multicentre study was designed to collect data on therapeutic sequences in patients with gastroenteropancreatic or thoracic NETs, admitted between 01/01/2011 and 31/07/2016. Both retrospective and prospective data were considered. For each sequence, PFS was evaluated from the beginning of the first line of therapy to the last progression according to RECIST 1.1.

Conference: 15th Annual ENETSConcerence (2018)

Presenting Author:

Authors: Faggiano A, Di Maio S, Tafuto S, Mocerino C, Di Sarno A,

Keywords: neuroendocrine tumor, medical therapy, sequence of treatments,